- Home
- EQIX vs BMY Comparison
EQIX vs BMY Comparison
Compare EQIX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQIX | BMY |
|---|---|---|
| Founded | 1998 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.2B | 110.2B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EQIX | BMY |
|---|---|---|
| Price | $800.85 | $55.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 14 |
| Target Price | ★ $946.42 | $57.64 |
| AVG Volume (30 Days) | 520.5K | ★ 14.3M |
| Earning Date | 02-11-2026 | 02-05-2026 |
| Dividend Yield | 2.34% | ★ 4.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.95 | 2.97 |
| Revenue | $9,076,000,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $8.01 | $0.28 |
| Revenue Next Year | $8.65 | N/A |
| P/E Ratio | $73.24 | ★ $19.06 |
| Revenue Growth | ★ 5.63 | 1.26 |
| 52 Week Low | $701.41 | $42.52 |
| 52 Week High | $953.41 | $63.33 |
Technical Indicators
Market Signals| Indicator | EQIX | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 62.43 | 62.18 |
| Support Level | $758.90 | $55.34 |
| Resistance Level | $813.45 | $57.04 |
| Average True Range (ATR) | 16.79 | 1.06 |
| MACD | 3.90 | -0.04 |
| Stochastic Oscillator | 82.24 | 80.82 |
Price Performance
Historical ComparisonAbout EQIX Equinix Inc. REIT
Equinix operates 260 data centers in 71 markets worldwide. It generates 44% of total revenue in the Americas, 35% in Europe, the Middle East, and Africa, and 21% in Asia-Pacific. The firm has more than 10,000 customers, including 2,100 network providers, across five verticals: cloud and IT services, content providers, network and mobile services, financial services, and enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from interconnection. Equinix operates as a real estate investment trust.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.